GE Ventures related stories
All articles and analysis
VC-backed Bit Stew Systems bought by strategic investor GEBit Stew Systems Inc, a Vancouver data integration platform for the industrial internet, has been acquired by GE Digital. Terms were not disclosed; however, the Globe and Mail reported http://www.theglobeandmail.com/technology/general-electric-buys-vancouver-startup-bit-stew-for-153-million/article32841507/ the deal's value at US$153 million. GE was previously a strategic investor in Bit Stew, leading its US$17.2 million Series B financing /canada/2015/5/bit-stew-to-expand-commercial-horizons-with-ge-led-17-2-mln-funding/ in May 2015. The company's data intelligence capabilities will be combined with Predix, GE’s operating system for the industrial internet, and will help GE advance its product offerings. Led by CEO Kevin Collins, Bit Stew first raised funding in a Yaletown Partners-led Series A round in late 2013. Its other investors included BDC Capital, Cisco Systems and Kensington Capital Partners.

- Iora Health racks up $75 mln Series D
Boston-based Iora Health, a healthcare company, has raised $75 million in Series D financing. Temasek led the round with participation from other investors that included.406 Ventures, Flare Capital Partners, F-Prime Capital, GE Ventures, Khosla Ventures, Polaris Partners and Rice Management Company.
- Evidation Health scores $15 mln
San Mateo, California-based Evidation Health, a provider of digital tools and technology for the healthcare industry, has raised $15 million in funding round. B Capital Group led the round with participation from GE Ventures, AMV, Fresco Capital and Pappas Ventures.
Clearpath Robotics gets $30 mln funding for industrial robots: ReutersCanada's Clearpath Robotics has raised US$30 million ($39.5 million) from backers, including the venture arms of Caterpillar Inc and its customer General Electric Co, to expand its industrial robot business, Reuters reported. The funding will power growth at the Kitchener, Ontario-based company's Otto Motors industrial division, created last year to provide self-driving vehicles to transport materials around warehouses and manufacturing facilities. Clearpath said while the likes of Tesla, Uber and Google are testing autonomous vehicles for use on public roads, its industrial vehicles are already commercially available.
Clearpath Robotics raises $39.5 mln in iNovia Capital-led roundClearpath Robotics Inc has secured about $39.5 million (US$30 million) in follow-on funding, adding to the $14 million raised in the company's Series A financing /canada/2015/3/rre-ventures-leads-funding-round-for-clearpath-robotics-2/ in early 2015. The latest round was led by Canadian venture capital firm iNovia Capital, with participation from Caterpillar Ventures, GE Ventures, Eclipse Ventures, RRE Ventures and Silicon Valley Bank. Founded in 2009, Kitchener, Ontario-based Clearpath is a provider of self-driving vehicle solutions to over 500 brands around the globe. Last year, it launched OTTO Motors to focus on vehicles for material transport inside manufacturing and warehouse operations. It plans to used the funds raised to grow the division.
- Allied Minds and GE Ventures launch new investment alliance
Allied Minds and GE Ventures have formed a partnership. According to terms of the deal both will invest in new and existing companies sourced from both Allied Minds and GE's pipelines.
- Sarcos Robotics takes in funding
Sarcos Robotics, a maker of industrial robots, has secured an undisclosed amount of funding. The investors included Caterpillar Ventures, GE Ventures, Cottonwood Technology Fund and Microsoft Corp. In addition to the funding, Peter Klein, former CFO of Microsoft, Ray Quintana, a general partner at Cottonwood Technology Fund, Ralph Taylor-Smith, a managing director at GE Ventures and Dennis Weibling have been added to Sarcos' board of directors.
- Chrono Therapeutics scores $47.6 mln Series B
Hayward, California-based digital drug therapy company Chrono Therapeutics has raised $47.6 million in Series B financing. Kaiser Permanente Ventures led the round with participation from other investors that included Endeavour Vision, Xeraya Capital, Labuan Ltd, Emergent Medical Partners, Canaan Partners, 5AM Ventures, Fountain Healthcare Partners, GE Ventures, Hikma Ventures, Cota Capital and Mission Bay Capital. In addition to the funding, Liz Rockett, director of Kaiser Permanente Ventures, has been added to Chrono Therapeutics' board of directors.
- Octiv snags $4.75 mln
Indianapolis-based Octiv, a sales productivity solutions provider, has raised $4.75 million in funding. The investors were GE Ventures, Greycroft Partners, High Alpha Capital and Allos Partners.